Cooperman Leon G
- SEC CIK
- 0000898382
- Latest filing
- Aug 14, 2026
The latest 13F from Cooperman Leon G covers Q2 2026 (filed Aug 14, 2026): 39 long positions worth $3.55B. The top 10 holdings make up 68.4% of the portfolio, and the largest is Vertiv Holdings Co (VRT) at 20.4%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 4
- Est. +$318.8M
- Added
- 7
- Est. +$101.9M
- Reduced
- 3
- Est. −$94.7M
- Sold out
- 6
- Est. −$251.4M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $3.55B
- +$499.4M (+16.4%) vs. prior quarter
- Positions
- 39
- −2 vs. prior quarter
- Top 10 concentration
- 68.4%
- Top 10 as share of value
- Turnover
- 10.5%
- Q2 2026, one quarter
- Average holding period
- 15.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $3.55B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 39 | $3.55B | VRTRKTET | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 41 | $3.05B | VRTRKTET | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 40 | $3.01B | RKTVRTET | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 41 | $3.20B | COOPVRTET | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 40 | $2.85B | COOPVRTET | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025Amended | 41 | $2.52B | COOPETAPO | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 45 | $2.64B | COOPETVRT | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 40 | $2.35B | COOPVRTET | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 52 | $2.37B | COOPETVRT | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 51 | $2.40B | COOPETAPO | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024Amended | 50 | $2.10B | COOPETAPO | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 54 | $1.91B | ETCOOPAPO | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 30, 2023 | 54 | $1.84B | COOPETLAD | vs. Q1 2023 | SEC |
| Q1 2023 | Aug 30, 2023 | 54 | $1.66B | ETCOOPDVN | vs. Q4 2022 | SEC |
| Q4 2022 | Aug 30, 2023 | 55 | $1.60B | DVNCOOPCI | vs. Q3 2022 | SEC |
| Q3 2022 | Aug 31, 2023 | 56 | $1.42B | DVNCOOPET | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 31, 2023 | 52 | $1.45B | GOOGLDVNCOOP | vs. Q1 2022 | SEC |
| Q1 2022 | Aug 31, 2023 | 53 | $1.90B | GOOGLDVNCOOP | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 56 | $1.99B | COOPGOOGLAthene Holding Ltd. | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 65 | $1.89B | COOPGOOGLAthene Holding Ltd. | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 67 | $1.78B | GOOGLCOOPAthene Holding Ltd. | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 55 | $1.60B | COOPGOOGLFISV | – | SEC |
13D and 13G filings
Companies where Cooperman Leon G reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
6 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FOAFinance of America Companies Inc. | 13G/A | 15.00%1.29M shares | +3.40 ppfrom 11.60% | Sep 2, 20252 filings | May 13, 2026 | SEC |
| WHKWhiteHawk Minerals Corp. | 13G | 12.40%3.26M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| PLGOPelagos Insurance Capital Ltd | 13G/A | 10.00%8.56M shares | +0.10 ppfrom 9.90% | Aug 27, 20256 filings | Aug 11, 2026 | SEC |
| DMACDiaMedica Therapeutics Inc. | 13G/A | 6.60%3.45M shares | +0.30 ppfrom 6.30% | Aug 27, 20253 filings | Feb 17, 2026 | SEC |
| ASHAshland Inc. | 13G | 6.40%2.92M shares | New | Aug 5, 20261 filing | Aug 5, 2026 | SEC |
| MANUManchester United plc | 13G/A | 5.20%2.93M shares | 0.00 ppfrom 5.20% | Oct 15, 20253 filings | May 13, 2026 | SEC |
Latest filings
36 filings on file made by Cooperman Leon G or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| WHKWhiteHawk Minerals Corp. | Aug 14, 20264:15 PM ET | 13G | 12.40%3.26M shares | New | Jun 30, 2026 | SEC |
| PLGOPelagos Insurance Capital Ltd | Aug 11, 20264:23 PM ET | 13G/A | 10.00%8.56M shares | +0.10 ppfrom 9.90% | Aug 4, 2026 | SEC |
| PLGOPelagos Insurance Capital Ltd | Aug 11, 20264:17 PM ET | 13G/A | 9.90%8.51M shares | +0.70 ppfrom 9.20% | Jun 30, 2026 | SEC |
| ASHAshland Inc. | Aug 5, 20264:12 PM ET | 13G | 6.40%2.92M shares | New | Jul 29, 2026 | SEC |
| MANUManchester United plc | May 13, 20264:23 PM ET | 13G/A | 5.20%2.93M shares | 0.00 ppfrom 5.20% | Mar 31, 2026 | SEC |
| FOAFinance of America Companies Inc. | May 13, 20264:20 PM ET | 13G/A | 15.00%1.29M shares | +3.40 ppfrom 11.60% | Mar 31, 2026 | SEC |
| PLGOPelagos Insurance Capital Ltd | May 13, 20264:17 PM ET | 13G/A | 9.20%7.98M shares | +2.40 ppfrom 6.80% | Mar 31, 2026 | SEC |
| STKLSunOpta Inc. | May 13, 20264:15 PM ET | 13G/A | 0.00%0 shares | −7.70 ppfrom 7.70%Below 5% | May 1, 2026 | SEC |
| STKLSunOpta Inc. | Feb 17, 20264:09 PM ET | 13G/A | 7.70%9.05M shares | +2.10 ppfrom 5.60% | Dec 31, 2025 | SEC |
| MANUManchester United plc | Feb 17, 20264:07 PM ET | 13G/A | 5.20%2.92M shares | +0.10 ppfrom 5.10% | Dec 31, 2025 | SEC |
| PLGOPelagos Insurance Capital Ltd | Feb 17, 20264:03 PM ET | 13G/A | 6.80%7.04M shares | +0.40 ppfrom 6.40% | Dec 31, 2025 | SEC |
| DMACDiaMedica Therapeutics Inc. | Feb 17, 20264:01 PM ET | 13G/A | 6.60%3.45M shares | +0.30 ppfrom 6.30% | Dec 31, 2025 | SEC |
| DMACDiaMedica Therapeutics Inc. | Oct 15, 20254:48 PM ET | 13G/A | 6.30%3.27M shares | +0.30 ppfrom 6.00% | Sep 30, 2025 | SEC |
| PLGOPelagos Insurance Capital Ltd | Oct 15, 20254:45 PM ET | 13G/A | 6.40%6.66M shares | +0.20 ppfrom 6.20% | Sep 30, 2025 | SEC |
| STKLSunOpta Inc. | Oct 15, 20254:44 PM ET | 13G/A | 5.60%6.67M shares | 0.00 ppfrom 5.60% | Sep 30, 2025 | SEC |
| MANUManchester United plc | Oct 15, 20254:42 PM ET | 13G | 5.10%2.86M shares | New | Feb 21, 2025 | SEC |
| FOAFinance of America Companies Inc. | Sep 2, 20258:21 PM ET | 13G | 11.60%1.29M shares | New | Apr 1, 2021 | SEC |
| DMACDiaMedica Therapeutics Inc. | Aug 27, 20254:24 PM ET | 13G | 6.00%3.11M shares | New | Jul 23, 2025 | SEC |
| PLGOPelagos Insurance Capital Ltd | Aug 27, 20254:23 PM ET | 13G | 6.20%6.53M shares | New | Jun 10, 2025 | SEC |
| STKLSunOpta Inc. | Aug 27, 20254:18 PM ET | 13G | 5.60%6.65M shares | New | Mar 13, 2025 | SEC |